The ICER value framework describes the conceptual framework and set of associated methods that guide the development of ICER evidence reports. The purpose of the value framework is to form the backbone of rigorous, transparent evidence reports that, as a basis for broader stakeholder and public engagement, will help the United States evolve toward a health care system that provides sustainable access to high-value care for all patients.
The initial framework was developed with input from a multi-stakeholder workgroup that included the perspective of patient advocates, clinical societies, life sciences companies, pharmaceutical benefit managers, and insurers. All participants provided input into the development of the value assessment framework but none should be assumed to approve of its approach.
Value Framework Update
ICER’s final update for 2017-2019 is now available.
View as webpage | View as PDF
In 2016, ICER’s existing value framework was opened to public comment as part of a planned update to ICER’s methods. During the public comment period, ICER received over 50 sets of comments from patients, clinicians, life science companies, and other stakeholders. In addition, ICER convened a one-day meeting with over 40 health care stakeholders to review the current Value Assessment Framework.
Based on feedback received during the public comment period and at the stakeholder meeting, ICER published a set of proposed changes to the Value Assessment Framework in February of 2017. This document was again opened to public comment until April 3, 2017. During this time, an additional 43 sets of comments were received, which are woven into the final document.
A regular update cycle is planned for every two years.
For those interested in a detailed explanation of the proposed updates to ICER’s Value Assessment Framework, watch a recording of Dr. Steven Pearson’s webinar detailing the changes here.
Download the slide presentation from the webinar here.